NEORECORMON Side Effects

6924980-5 | Nephrogenic Systemic Fibrosis
on Jul 22, 2010 Female patient from DENMARK , weighting 127.9 lb, was treated with Neorecormon (View Usage). Patient experienced the following unwanted or unexpected effects: nephrogenic systemic fibrosis. Neorecormon dosage: . During the same period patient was treated with VEPICOMBIN (View Vepicombin Review and Vepicombin Label ), C VITAMIN (View C-vitamin Review and C-vitamin Label ), CORODIL (View Corodil Review and Corodil Label ), FOLINSYRE (View Folinsyre Review and Folinsyre Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IPREN (View Ipren Review and Ipren Label ), LONGOVITAL (View Longovital Review and Longovital Label ), MAREVAN (View Marevan Review and Marevan Label ).

6698166-6 | Nephrogenic Systemic Fibrosis
Patient was taking Neorecormon (View Usage). Patient had the following side effects: nephrogenic systemic fibrosis on Apr 21, 2010 from GERMANY Additional patient health information: Female patient , weighting 143.3 lb, . Neorecormon dosage: . During the same period patient was treated with VEPICOMBIN (View Vepicombin Review and Vepicombin Label ), C VITAMIN (View C-vitamin Review and C-vitamin Label ), CORODIL (View Corodil Review and Corodil Label ), FOLINSYRE (View Folinsyre Review and Folinsyre Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IPREN (View Ipren Review and Ipren Label ), LONGOVITAL (View Longovital Review and Longovital Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6377010-0 | Nephrogenic Systemic Fibrosis
Adverse event was reported on Sep 21, 2009 by a Female patient taking Neorecormon (View Usage) (Dosage: ) . Location: SWEDEN , weighting 143.3 lb, After Neorecormon was administered, patient had the following side effects: nephrogenic systemic fibrosis. During the same period patient was treated with VEPICOMBIN (View Vepicombin Review and Vepicombin Label ), C VITAMIN (View C-vitamin Review and C-vitamin Label ), CORODIL (View Corodil Review and Corodil Label ), FOLINSYRE (View Folinsyre Review and Folinsyre Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IPREN (View Ipren Review and Ipren Label ), LONGOVITAL (View Longovital Review and Longovital Label ), MAREVAN (View Marevan Review and Marevan Label ).

6042377-X | Malaise, Nausea, Renal Failure Chronic
on Jan 09, 2009 Male patient from GERMANY , 70 years of age, weighting 201.7 lb, was diagnosed with anaemia, hypertension, helicobacter gastritis, hypercholesterolaemia, hyperparathyroidism secondary and was treated with Neorecormon (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, nausea (What is nausea?), renal failure chronic. Neorecormon dosage: 4000 Iu 2x Monthly. During the same period patient was treated with MOXONIDINE (View Moxonidine Review and Moxonidine Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), TOREM (View Torem Review and Torem Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), EINSALPHA (View Einsalpha Review and Einsalpha Label ), EBRANTIL (View Ebrantil Review and Ebrantil Label ), DIOVANE (View Diovane Review and Diovane Label ). Patient was hospitalized.


5076941-1 | Hypothyroidism
on Jul 31, 2006 Female patient from FRANCE , 78 years of age, was diagnosed with anaemia, gastric ulcer, parkinson's disease (What is parkinson's disease?), epilepsy (What is epilepsy?), cerebrovascular accident and was treated with Neorecormon (View Usage). Patient had the following side effects: hypothyroidism. Neorecormon dosage: 4000 Iu. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MODOPAR (View Modopar Review and Modopar Label ), DEPAKENE (View Depakene Review and Depakene Label ), CORDARONE (View Cordarone Review and Cordarone Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.